The new era of primary HPV screening for prevention of invasive cervical cancer

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

We now know that persistent cervical infections by certain types of human papillomavirus (HPV) designated as high-risk, carcinogenic or cancer-associated, cause virtually all invasive cervical cancer. The discovery of oncogenic HPV as the necessary cause of invasive cervical cancer has led to revolutionary advances in prevention, including the development of sensitive molecular HPV testing for cervical cancer screening. Using high-risk HPV testing for the primary screen shifts the use of the Pap test from the general population to those women at risk of cervical cancer, high-risk HPV positives. In high-resource settings, using high risk HPV testing as the primary cervical cancer screening test could increase the efficiency of current screening programs, more effectively identify women at risk for adenocarcinoma, and combined with self-collection, reach medically unserved populations that experience a disproportionate burden of invasive cervical cancer.

Original languageEnglish (US)
Pages (from-to)209-214
Number of pages6
JournalCancer Forum
Volume38
Issue number3
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Uterine Cervical Neoplasms
Early Detection of Cancer
Papanicolaou Test
Population
Adenocarcinoma
Infection
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The new era of primary HPV screening for prevention of invasive cervical cancer. / Castle, Philip E.

In: Cancer Forum, Vol. 38, No. 3, 01.11.2014, p. 209-214.

Research output: Contribution to journalReview article

@article{ecb9162ecbfa4d2998bf97b71138fc8a,
title = "The new era of primary HPV screening for prevention of invasive cervical cancer",
abstract = "We now know that persistent cervical infections by certain types of human papillomavirus (HPV) designated as high-risk, carcinogenic or cancer-associated, cause virtually all invasive cervical cancer. The discovery of oncogenic HPV as the necessary cause of invasive cervical cancer has led to revolutionary advances in prevention, including the development of sensitive molecular HPV testing for cervical cancer screening. Using high-risk HPV testing for the primary screen shifts the use of the Pap test from the general population to those women at risk of cervical cancer, high-risk HPV positives. In high-resource settings, using high risk HPV testing as the primary cervical cancer screening test could increase the efficiency of current screening programs, more effectively identify women at risk for adenocarcinoma, and combined with self-collection, reach medically unserved populations that experience a disproportionate burden of invasive cervical cancer.",
author = "Castle, {Philip E.}",
year = "2014",
month = "11",
day = "1",
language = "English (US)",
volume = "38",
pages = "209--214",
journal = "Cancer Forum",
issn = "0311-306X",
publisher = "The Cancer Council Australia",
number = "3",

}

TY - JOUR

T1 - The new era of primary HPV screening for prevention of invasive cervical cancer

AU - Castle, Philip E.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - We now know that persistent cervical infections by certain types of human papillomavirus (HPV) designated as high-risk, carcinogenic or cancer-associated, cause virtually all invasive cervical cancer. The discovery of oncogenic HPV as the necessary cause of invasive cervical cancer has led to revolutionary advances in prevention, including the development of sensitive molecular HPV testing for cervical cancer screening. Using high-risk HPV testing for the primary screen shifts the use of the Pap test from the general population to those women at risk of cervical cancer, high-risk HPV positives. In high-resource settings, using high risk HPV testing as the primary cervical cancer screening test could increase the efficiency of current screening programs, more effectively identify women at risk for adenocarcinoma, and combined with self-collection, reach medically unserved populations that experience a disproportionate burden of invasive cervical cancer.

AB - We now know that persistent cervical infections by certain types of human papillomavirus (HPV) designated as high-risk, carcinogenic or cancer-associated, cause virtually all invasive cervical cancer. The discovery of oncogenic HPV as the necessary cause of invasive cervical cancer has led to revolutionary advances in prevention, including the development of sensitive molecular HPV testing for cervical cancer screening. Using high-risk HPV testing for the primary screen shifts the use of the Pap test from the general population to those women at risk of cervical cancer, high-risk HPV positives. In high-resource settings, using high risk HPV testing as the primary cervical cancer screening test could increase the efficiency of current screening programs, more effectively identify women at risk for adenocarcinoma, and combined with self-collection, reach medically unserved populations that experience a disproportionate burden of invasive cervical cancer.

UR - http://www.scopus.com/inward/record.url?scp=84916634303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916634303&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84916634303

VL - 38

SP - 209

EP - 214

JO - Cancer Forum

JF - Cancer Forum

SN - 0311-306X

IS - 3

ER -